A conceptual framework for a long-term economic model for the treatment of attention-deficit/hyperactivity disorder

被引:2
|
作者
Nagy, Balazs [1 ,2 ]
Setyawan, Juliana [3 ]
Coghill, David [4 ,5 ,6 ,7 ]
Soroncz-Szabo, Tamas [1 ]
Kalo, Zoltan [1 ,2 ]
Doshi, Jalpa A. [8 ,9 ]
机构
[1] Syreon Res Inst, Thokoly Str 119, H-1146 Budapest, Hungary
[2] Eotvos Lorand Univ, Dept Hlth Policy & Hlth Econ, Budapest, Hungary
[3] Shire, Global HEOR & Epidemiol, Wayne, PA USA
[4] Univ Dundee, Med Res Inst, Div Neurosci, Dundee, Scotland
[5] Ninewells Hosp & Med Sch, Dundee, Scotland
[6] Univ Melbourne, Royal Childrens Hosp, Fac Med Dent & Hlth Sci, Dept Paediat, Parkville, Vic, Australia
[7] Univ Melbourne, Royal Childrens Hosp, Fac Med Dent & Hlth Sci, Dept Psychiat, Parkville, Vic, Australia
[8] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA
关键词
ADHD; long-term model; conceptual model framework; long-term disease outcomes; ADHD therapy; DEFICIT HYPERACTIVITY DISORDER; COST-EFFECTIVENESS; SMOKING-CESSATION; LIFE-SPAN; ADHD; CARE; VARENICLINE; ADOLESCENTS; POPULATION; DEPRESSION;
D O I
10.1080/14737167.2017.1271325
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Models incorporating long-term outcomes (LTOs) are not available to assess the health economic impact of attention-deficit/hyperactivity disorder (ADHD).Objective: Develop a conceptual modelling framework capable of assessing long-term economic impact of ADHD therapies.Methods: Literature was reviewed; a conceptual structure for the long-term model was outlined with attention to disease characteristics and potential impact of treatment strategies.Results: The proposed model has four layers: i) multi-state short-term framework to differentiate between ADHD treatments; ii) multiple states being merged into three core health states associated with LTOs; iii) series of sub-models in which particular LTOs are depicted; iv) outcomes collected to be either used directly for economic analyses or translated into other relevant measures.Conclusions: This conceptual model provides a framework to assess relationships between short- and long-term outcomes of the disease and its treatment, and to estimate the economic impact of ADHD treatments throughout the course of the disease.
引用
收藏
页码:283 / 292
页数:10
相关论文
共 50 条
  • [1] Long-term prognosis in attention-deficit/hyperactivity disorder
    Mannuzza, S
    Klein, RG
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2000, 9 (03) : 711 - +
  • [2] Long-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorder
    Wilens, Timothy E.
    Newcorn, Jeffrey H.
    Kratochvil, Christopher J.
    Gao, Haitao
    Thomason, Christine K.
    Rogers, Ann K.
    Feldman, Peter D.
    Levine, Louise R.
    JOURNAL OF PEDIATRICS, 2006, 149 (01): : 112 - 119
  • [3] Long-term academic outcomes of attention-deficit hyperactivity disorder and effects of treatment
    Hodgkins, Paul
    Kahle, Jennifer
    Kewley, Geoff
    Madhoo, Manisha
    Arnold, L. Eugene
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S231 - S232
  • [4] Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
    Hechtman L.
    Current Psychiatry Reports, 2006, 8 (5) : 398 - 408
  • [5] Attention-deficit/hyperactivity disorder treatment: what are the long-term cardiovascular risks?
    Hammerness, Paul G.
    Karampahtsis, Chris
    Babalola, Ronke
    Alexander, Mark E.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (04) : 543 - 551
  • [6] Update on Long-term Stimulant Medication Treatment of Attention-Deficit Hyperactivity Disorder
    Barbaresi, William J.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2014, 35 (07): : 446 - 447
  • [7] Long-term treatment effects of atomoxetine in adults with attention-deficit/hyperactivity disorder (ADHD)
    Michelson, D
    Adler, L
    Spencer, T
    Milton, D
    Jones, D
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S458 - S458
  • [8] Long-Term Cardiovascular Risk Associated With Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
    Holt, Anders
    Strange, Jarl E.
    Rasmussen, Peter Vibe
    Nouhravesh, Nina
    Nielsen, Sebastian Kinnberg
    Sindet-Pedersen, Caroline
    Fosbol, Emil Loldrup
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    McGettigan, Patricia
    Schou, Morten
    Lamberts, Morten
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (19) : 1870 - 1882
  • [9] The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder
    Hazell, Philip
    CURRENT OPINION IN PSYCHIATRY, 2011, 24 (04) : 286 - 290
  • [10] Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder
    Kratochvil, Christopher J.
    Wilens, Timothy E.
    Greenhill, Laurence L.
    Gao, Haitao
    Baker, Kurt D.
    Feldman, Peter D.
    Gelowitz, Douglas L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (08): : 919 - 927